These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12077528)

  • 1. Levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: an open study.
    Kawada A; Aragane Y; Tezuka T
    Dermatology; 2002; 204(4):301-2. PubMed ID: 12077528
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness of once-daily levofloxacin for inflammatory acne with high concentrations in the lesions.
    Kawada A; Wada T; Oiso N
    J Dermatol; 2012 Jan; 39(1):94-6. PubMed ID: 21545499
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico.
    González R; Welsh O; Ocampo J; Hinojosa-Robles RM; Vera-Cabrera L; Delaney ML; Gómez M
    Int J Dermatol; 2010 Sep; 49(9):1003-7. PubMed ID: 20931669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the bactericidal effects of indocyanine green- and methyl aminolevulinate-based photodynamic therapy on Propionibacterium acnes as a new treatment for acne.
    Choi SH; Seo JW; Kim KH
    J Dermatol; 2018 Jul; 45(7):824-829. PubMed ID: 29722425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A profile of Propionibacterium acnes resistance and sensitivity at a tertiary dermatological centre in Singapore.
    Yang SS; Long V; Liau MM; Lee SH; Toh M; Teo J; Tan C; Aw D
    Br J Dermatol; 2018 Jul; 179(1):200-201. PubMed ID: 29368337
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris.
    Vogt K; Hahn H; Hermann J; Haustein UF; Blume U; Gollnick H; Orfanos CE
    Drugs; 1995; 49 Suppl 2():266-8. PubMed ID: 8549327
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult acne in women is not associated with a specific type of Cutibacterium acnes.
    Saint-Jean M; Corvec S; Nguyen JM; Le Moigne M; Boisrobert A; Khammari A; Dréno B
    J Am Acad Dermatol; 2019 Sep; 81(3):851-852. PubMed ID: 30905801
    [No Abstract]   [Full Text] [Related]  

  • 14. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
    Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
    J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
    Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
    Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
    Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C; Ergin S; Kaleli I; Kaçar N; Sengül M; Erdoğan BS
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cosmetics containing purified honeybee (Apis mellifera L.) venom on acne vulgaris.
    Han SM; Lee KG; Pak SC
    J Integr Med; 2013 Sep; 11(5):320-6. PubMed ID: 24063779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.